Progressive Supranuclear Palsy Medical Services in China

Progressive supranuclear palsy (PSP) is a rare, progressive neurodegenerative disorder characterized by tau protein accumulation in basal ganglia, brainstem, and cortical regions. Clinically, it manifests with early postural instability, vertical supranuclear gaze palsy—particularly downward gaze restriction—bradykinesia, axial rigidity, dysphagia, and cognitive decline, often misdiagnosed initially as Parkinson’s disease or corticobasal syndrome. There is no disease-modifying therapy; management remains symptomatic and multidisciplinary, involving neurology, speech-language pathology, physical and occupational therapy, and palliative care. Accurate diagnosis relies on clinical criteria (e.g., MDS-PSP criteria), MRI demonstrating midbrain atrophy (“hummingbird” or “penguin” sign), and increasingly, tau PET imaging or CSF biomarkers under research protocols.

China offers distinct advantages for PSP care: leading neurology centers—including Beijing Tiantan Hospital, Shanghai Huashan Hospital, and Guangzhou Sun Yat-sen Memorial Hospital—host specialized movement disorder units with deep expertise in atypical parkinsonism. Advanced infrastructure includes 3T MRI with quantitative volumetry, high-resolution diffusion tensor imaging, and access to investigational tau-targeted therapeutics through international clinical trial partnerships. Real-world outcomes reflect improved symptom control and quality-of-life preservation via personalized rehabilitation protocols and early dysphagia intervention. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising diagnostic rigor or therapeutic continuity. As a dedicated medical tourism agency, we facilitate seamless international patient journeys—coordinating specialist consultations, arranging hospital admissions, providing transparent, all-inclusive pricing, and delivering end-to-end support from visa assistance to post-discharge follow-up coordination.

Medical Travel to China Guide: Progressive Supranuclear Palsy (Neurology)

Visa & Entry: Most patients require a Chinese Medical Visa (Q2 or S2), obtainable with an invitation letter from our partnered neurology hospitals—our team handles documentation, appointment verification, and embassy coordination.

Medical Insurance & Payment: China does not accept foreign health insurance directly; however, we provide transparent, itemized cost estimates upfront—including specialist consultations, MRI/PET-CT, neuropsychological assessments, and rehabilitation planning. Payments are made securely in USD or EUR via bank transfer or credit card, with receipts issued for potential reimbursement claims at home. We assist with pre-travel financial planning and clarify all fees before commitment.

Accommodation & Companions: We arrange hotel stays near partner hospitals (e.g., Beijing Tiantan Hospital or Shanghai Huashan Hospital), with options for caregiver-friendly rooms and accessible transport. Companions receive visa support and local orientation.

Follow-Up Care: Post-consultation, our neurology coordinators schedule virtual check-ins every 4–6 weeks, share translated reports, and liaise with your home physician to ensure continuity—no extra charge.